{
    "clinical_study": {
        "@rank": "166549", 
        "acronym": "PERFECT FAST", 
        "arm_group": [
            {
                "arm_group_label": "PecFent nasal spray", 
                "arm_group_type": "Experimental", 
                "description": "Patients that have signed the ICF and met inclusion and exclusion criteria are randomly assigned 1:1 to receive one of the following IP-BTP treatments:\nFentanyl pectin nasal spray (FPNS)\nPhysician choice-Usual Care (PC-UC)"
            }, 
            {
                "arm_group_label": "Physician choice-Usual Care (PC-UC)", 
                "arm_group_type": "Active Comparator", 
                "description": "Patients that have signed the ICF and met inclusion and exclusion criteria are randomly assigned 1:1 to receive one of the following IP-BTP treatments:\nFentanyl pectin nasal spray (FPNS)\nPhysician choice-Usual Care (PC-UC)"
            }
        ], 
        "brief_summary": {
            "textblock": "The primary objective of the present phase IIIb study is to assess the efficacy of FPNS\n      compared with Physician Choice-Usual Care (PC-UC) in the management of swallowing IP-BTP in\n      head and neck cancer patients undergoing radiotherapy with or without chemotherapy."
        }, 
        "brief_title": "PEctin Rapid Fentanyl Efficacy Clinical Trial For pAin at Swallowing Undergoing radioTherapy", 
        "completion_date": {
            "#text": "July 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Incidental Predictable Breakthrough Pain (IP-BTP)", 
        "detailed_description": {
            "textblock": "Population: In and out patients with head and neck cancer undergoing radiotherapy,\n      regardless of the day of the radiotherapic treatment, with or without chemotherapy and\n      treated with analgesic opioids at a stable dose equivalent to 60 mg oral morphine to control\n      background pain but with uncontrolled pain at swallowing (moderate/severe intensity: \u2265 4 on\n      a NRS 0-10).\n\n      Study design: Patients that have signed the ICF and met inclusion and exclusion criteria are\n      randomly assigned 1:1 to receive one of the following\n\n      IP-BTP treatments:\n\n        1. Fentanyl pectin nasal spray (FPNS)\n\n        2. Physician choice-Usual Care (PC-UC) Each patient will assume the drug no more than 3\n           episode a day (at main meals: breakfast, lunch and dinner) for 15 episodes in total in\n           5/6 consecutive days. At each episode the patients will record the pain at baseline (\n           before drug administration ), and 10, 20 30 minutes after assuming FPNS or PC-UC."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Male and female aged 18 years or over\n\n          -  Diagnosis of stage III-IV cancer of oral cavity, oropharynx, hypopharynx, larynx,\n             salivary gland cancer\n\n          -  Receiving radiation therapy (RT) with or without concurrent platinum based\n             chemotherapy or cetuximab as first line treatment or as postoperative adjuvant\n             treatment\n\n          -  Background pain managed with a stable fixed dose of opioid equivalent to 60mg oral\n             morphine daily\n\n          -  Uncontrolled pain (IP-BTP) during swallowing with an intensity \u22654 on an 11-point\n             numeric scale (0=no pain; 10=worst possible pain). This pain will have to be measured\n             with the ingestion of a solid/liquid food (depending on the ability to swallow or\n             less solid foods of the patient at moment)\n\n          -  Patients able to receive a nasal spray therapy\n\n          -  Willing and able to sign an informed consent form\n\n          -  Females with childbearing potential must provide a negative pregnancy test and both\n             males and females must be using adequate contraception during the study\n\n        Exclusion Criteria:\n\n          -  Patients with known metastatic disease\n\n          -  Known hypersensitivity to opioids, to Fentanyl or to drugs used in the PC-UC, and/or\n             to study medications' formulation ingredients\n\n          -  Patients with impaired chemistry laboratory exams, assessed as routine clinical\n             practice before radiotherapy start:\n\n               1. Hepatic function:\n\n                  Total bilirubin > 2 times the upper-normal limit (ULN) Serum transaminase > 5\n                  times ULN\n\n               2. Renal function:\n\n        Serum creatinine concentration > 2 times ULN\n\n          -  Pregnant or breastfeeding women\n\n          -  Patients unlikely to comply with the protocol or unable to understand the nature,\n             scope and possible consequences of the study\n\n          -  Patients planned to receive other investigational treatments during study period\n\n          -  Patients with moderate to severe respiratory impairment"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "158", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 21, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01980498", 
            "org_study_id": "MOLT-2013-02", 
            "secondary_id": "2013-001271-20"
        }, 
        "intervention": [
            {
                "arm_group_label": "PecFent nasal spray", 
                "description": "The first dose of FPNS will be 100 mcg dose. It will be increased until 800 mcg dose.", 
                "intervention_name": "Fentanyl pectin nasal spray (FPNS)", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Physician choice-Usual Care (PC-UC)", 
                "description": "The PC-UC will be started at a dose according to the physician choice. If this dose of PC-UC is effective on pain control, at all the following meals the patient will take the same dose of PC-UC. If the dose of PC-UC results non effective on pain control, at the following meal the patient will take an increased dose of the same PC-UC drug or change the PC-UC drug, according to the physician choice.", 
                "intervention_name": "Physician choice-Usual care (PC-UC)", 
                "intervention_type": "Drug", 
                "other_name": "PC-UC is any drug used in clinical use for treating IP-BTP"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Fentanyl", 
                "Pectin"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "November 28, 2013", 
        "location": [
            {
                "contact": {
                    "last_name": "Elisabetta Parisi"
                }, 
                "facility": {
                    "address": {
                        "city": "Meldola", 
                        "country": "Italy", 
                        "state": "Forl\u00ec - Cesena", 
                        "zip": "47014"
                    }, 
                    "name": "Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (I.R.S.T.)"
                }, 
                "investigator": {
                    "last_name": "Elisabetta Parisi", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Elena Delmastro"
                }, 
                "facility": {
                    "address": {
                        "city": "Candiolo", 
                        "country": "Italy", 
                        "state": "Torino", 
                        "zip": "10060"
                    }, 
                    "name": "Istituto per la Ricerca e la Cura del Cancro a carattere Scientifico - IRCC"
                }, 
                "investigator": {
                    "last_name": "Elena Delmastro", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Giuseppe Azzarello"
                }, 
                "facility": {
                    "address": {
                        "city": "Mirano", 
                        "country": "Italy", 
                        "state": "Venezia", 
                        "zip": "30035"
                    }, 
                    "name": "Presidio Ospedaliero Mirano Azienda Ulss 13"
                }, 
                "investigator": {
                    "last_name": "Giuseppe Azzarello", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Giovanni Frezza"
                }, 
                "facility": {
                    "address": {
                        "city": "Bologna", 
                        "country": "Italy", 
                        "zip": "40139"
                    }, 
                    "name": "Ospedale Bellaria"
                }, 
                "investigator": {
                    "last_name": "Giovanni Frezza", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Michela Buglione"
                }, 
                "facility": {
                    "address": {
                        "city": "Brescia", 
                        "country": "Italy", 
                        "zip": "25123"
                    }, 
                    "name": "Azienda Ospedaliera \"Spedali civili\" di Brescia"
                }, 
                "investigator": {
                    "last_name": "Michela Buglione", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Nerina Denaro"
                }, 
                "facility": {
                    "address": {
                        "city": "Cuneo", 
                        "country": "Italy", 
                        "zip": "12100"
                    }, 
                    "name": "Ospedale Santa Croce e Carl\u00e8"
                }, 
                "investigator": {
                    "last_name": "Nerina Denaro", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Gianpaolo Biti"
                }, 
                "facility": {
                    "address": {
                        "city": "Firenze", 
                        "country": "Italy", 
                        "zip": "50134"
                    }, 
                    "name": "Azienda Ospedaliera universitaria Careggi"
                }, 
                "investigator": {
                    "last_name": "Gianpaolo Biti", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Michela Marcenaro"
                }, 
                "facility": {
                    "address": {
                        "city": "Genova", 
                        "country": "Italy", 
                        "zip": "16132"
                    }, 
                    "name": "IRCCS AOU San Martino-IST Istituto Nazionale per la Ricerca sul Cancro"
                }, 
                "investigator": {
                    "last_name": "Michela Marcenaro", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Fabio Piazza"
                }, 
                "facility": {
                    "address": {
                        "city": "Mantova", 
                        "country": "Italy", 
                        "zip": "46100"
                    }, 
                    "name": "Ospedale Carlo Poma"
                }, 
                "investigator": {
                    "last_name": "Fabio Piazza", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Daniela Alterio"
                }, 
                "facility": {
                    "address": {
                        "city": "Milano", 
                        "country": "Italy", 
                        "zip": "20141"
                    }, 
                    "name": "Istituto Europeo di Oncologia"
                }, 
                "investigator": {
                    "last_name": "Daniela Alterio", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Paolo Bossi, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Milano", 
                        "country": "Italy", 
                        "zip": "20133"
                    }, 
                    "name": "Fondazione IRCCS Istituto Nazionale Tumori"
                }, 
                "investigator": {
                    "last_name": "Paolo Bossi", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Italo Dell'Oca"
                }, 
                "facility": {
                    "address": {
                        "city": "Milano", 
                        "country": "Italy", 
                        "zip": "20132"
                    }, 
                    "name": "Ospedale San Raffaele"
                }, 
                "investigator": {
                    "last_name": "Italo Dell'Oca", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Mauro Palazzi"
                }, 
                "facility": {
                    "address": {
                        "city": "Milano", 
                        "country": "Italy", 
                        "zip": "20162"
                    }, 
                    "name": "Ospedale Niguarda Ca' Granda"
                }, 
                "investigator": {
                    "last_name": "Mauro Palazzi", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Francesco Caponigro"
                }, 
                "facility": {
                    "address": {
                        "city": "Napoli", 
                        "country": "Italy", 
                        "zip": "80131"
                    }, 
                    "name": "Istituto Nazionale Tumori IRCCS - Fondazione Pascale"
                }, 
                "investigator": {
                    "last_name": "Francesco Caponigro", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Vincenzo Valentini"
                }, 
                "facility": {
                    "address": {
                        "city": "Roma", 
                        "country": "Italy", 
                        "zip": "00168"
                    }, 
                    "name": "Policlinico Universitario Gemelli di Roma"
                }, 
                "investigator": {
                    "last_name": "Vincenzo Valentini", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Laura Marucci"
                }, 
                "facility": {
                    "address": {
                        "city": "Roma", 
                        "country": "Italy", 
                        "zip": "00144"
                    }, 
                    "name": "Istituto Nazionale Tumori Regina Elena"
                }, 
                "investigator": {
                    "last_name": "Laura Marucci", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Giovanni Mandoliti"
                }, 
                "facility": {
                    "address": {
                        "city": "Rovigo", 
                        "country": "Italy", 
                        "zip": "45100"
                    }, 
                    "name": "Ospedale Santa Maria della Misericordia"
                }, 
                "investigator": {
                    "last_name": "Giovanni Mandoliti", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Mario Airoldi"
                }, 
                "facility": {
                    "address": {
                        "city": "Torino", 
                        "country": "Italy", 
                        "zip": "10126"
                    }, 
                    "name": "A.O. Citt\u00e0 della Salute e della Scienza - Ospedale Dermatologico S. Lazzaro"
                }, 
                "investigator": {
                    "last_name": "Mario Airoldi", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Andrea Bolner"
                }, 
                "facility": {
                    "address": {
                        "city": "Trento", 
                        "country": "Italy", 
                        "zip": "38122"
                    }, 
                    "name": "Ospedale di Trento - Presidio Ospedaliero Santa Chiara"
                }, 
                "investigator": {
                    "last_name": "Andrea Bolner", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Maria Grazia Ghi"
                }, 
                "facility": {
                    "address": {
                        "city": "Venezia Mestre", 
                        "country": "Italy"
                    }, 
                    "name": "Azienda U.L.S.S. 12 Veneziana"
                }, 
                "investigator": {
                    "last_name": "Maria Grazia Ghi", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "Italy"
        }, 
        "number_of_arms": "2", 
        "official_title": "Multicenter Randomized Open Trial to Evaluate Efficacy of Fentanyl Pectin Nasal Spray vs Physician Choice-Usual Care in Reducing Incidental Predictable Breakthrough Pain at Swallowing in Head/Neck Cancer Patients Undergoing Radiotherapy", 
        "overall_contact": {
            "email": "Lisa.Licitra@istitutotumori.mi.it", 
            "last_name": "Lisa Licitra, MD"
        }, 
        "overall_contact_backup": {
            "email": "Paolo.Bossi@istitutotumori.mi.it", 
            "last_name": "Paolo Bossi, MD"
        }, 
        "overall_official": {
            "affiliation": "Fondazione IRCCS - Istituto Nazionale Tumori - Milano (Italy)", 
            "last_name": "Lisa Licitra, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": [
                "Italy: Ethics Committee", 
                "Italy: The Italian Medicines Agency"
            ]
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Difference in the mean intensity of IP-BTP related to swallowing from the baseline to 20 minutes after taking FPNS/PC-UC (PID20).", 
            "safety_issue": "No", 
            "time_frame": "up to 6 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01980498"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "The difference in the mean intensity of IP-BTP related to swallowing from the baseline to 10 and 30 minutes after assuming FPNS/PC-UC", 
                "safety_issue": "No", 
                "time_frame": "up to 6 days"
            }, 
            {
                "measure": "Administration of rescue therapy", 
                "safety_issue": "No", 
                "time_frame": "up to 6 days"
            }, 
            {
                "measure": "Safety and tolerability", 
                "safety_issue": "Yes", 
                "time_frame": "up to 6 days"
            }, 
            {
                "measure": "Patient's pain relief measured at the end of the study period through the 5-points numeric scale (0=none; 4=complete)", 
                "safety_issue": "No", 
                "time_frame": "Day 6"
            }
        ], 
        "source": "L.Molteni & C. dei F.lli  Alitti-Soc. di Esercizio S.p.A.", 
        "sponsors": {
            "collaborator": {
                "agency": "Consorzio Mario Negri Sud", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "L.Molteni & C. dei F.lli  Alitti-Soc. di Esercizio S.p.A.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}